ATX amplia therapeutics limited

Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US, page-7

  1. 2,162 Posts.
    lightbulb Created with Sketch. 672
    Absolutely great news

    Having approval such as this, one could Imagine it will simplify the process when FDA approval is required in America. As we position ourselves with narmafotinib to be the preferred drug to tackle pancreatic cancer.
    The largest healthcare market in the world.


    I’m surprised you still buy 8.1 cents …. incredible


    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $114.3M
Open High Low Value Volume
24.0¢ 24.0¢ 22.8¢ $697.7K 3.001M

Buyers (Bids)

No. Vol. Price($)
9 613515 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 655770 23
View Market Depth
Last trade - 12.32pm 01/08/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.